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E-mail address: waseem_anw@yahoo.com (W. HasInﬂuence of pH on the extent of lipid peroxidation and the anti-oxidant potential of an organosele-
nium compound is explored. Acidosis increased the rate of lipid peroxidation both in the absence
and presence of Fe (II) in rat’s brain, kidney and liver homogenate and phospholipids extract from
egg yolk. The organoselenium compound signiﬁcantly protected lipids from peroxidation, both in
the absence and presence of Fe (II). Changing the pH of the reaction medium did not alter the
anti-oxidant activity of the tested compound. This study provides in vitro evidence for acidosis-
induced oxidative stress in brain, kidney, liver homogenate and phospholipids extract and the
anti-oxidant action of the tested organoselenium compound.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The role of iron in catalyzing oxygen-derived free radical pro-
duction is well known, and there is evidence that free radicals
may be a primary cause of cerebral damage during ischemia and
post ischemic reperfusion [1]. The pH of tissue could modulate
the ability of iron to participate in detrimental lipid peroxidation
reactions. It has been suggested that metabolic changes induced
by ischemia, such as acidosis [2] lead to intracellular iron delocal-
ization [3] providing a source of iron in a form capable of catalyz-
ing free radical production. Thus, the fall in intracellular pH that is
associated with ischemia cannot only inﬂuence metabolic pro-
cesses, but it can also potentate or act sinergically with oxidative
stress, contributing to increased cellular injury. Iron is more solu-
ble at lower pH values; therefore, we hypothesized that decreasing
the pH of the reaction medium will lead to increased lipid
peroxidation. For this purpose we have studied the effect of pH
on Fe (II)-mediated lipid peroxidation in rat’s brain, kidney, liver
homogenates and phospholipids extract from egg yolk by measur-
ing thiobarbituric acid-reactive species (TBARS).
Organoselenium compounds have been described to possess
very interesting biological activities. Reports have shown that
these selenium-containing organic compounds are generally more
potent anti-oxidants than classical anti-oxidants and this fact
serves as an impetus for an increased interest in the rational designchemical Societies. Published by E
san).of synthetic organoselenium compounds [4,5]. From a hypothetical
point of view, the formation of stables selenolate (Se1) ions can
increase the reducing properties of these moieties on the organ-
ochalcogenides and hypothetically can increase their anti-oxidant
properties. However, there is no data in the literature supporting
this assumption. Thus, to get a deeper insight into the potential
use of an organoselenium compound 2-((1-(2-(2-(2-(1-(2-hydroxy-
benzylideneamino) ethyl) phenyl) diselanyl) phenyl) ethylimino)
methyl) phenol (Compound A) (Fig. 1) as a possible pharmacolog-
ical agent, we have determined for the ﬁrst time the inﬂuence of
pH on protective effect of Compound A in vitro at different pH
ranging from low (acidic) to physiological values in rat’s brain, kid-
ney, liver and phospholipids extract from egg yolk.
2. Materials and methods
Compound A (Fig. 1) was synthesized according to literature
methods [6,7] with little modiﬁcations. Analysis of the 1H NMR
and 13C NMR spectra showed that the compound obtained (with
99.9% purity) presented analytical and spectroscopic data in full
agreement with their assigned structure. All other chemicals were
purchased from standard suppliers.
Brain, kidney and liver was removed from adult male wistar
rats, while phospholipids were extracted from eggs yolk by a solu-
tion 3:2 of hexane-isopropanol in the proposition of 1 g of egg yolk
to 10 ml of this solution. The mixture was ﬁltered and put in the
rotary evaporator with the maximum temperature of 60 C. Extract
was weighed and dissolved in distilled water in the proposition oflsevier B.V. All rights reserved.
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Fig. 1. Chemical structure of Compound A, i.e. 2-((1-(2-(2-(2-(1-(2-hydroxybenzy-
lideneamino) ethyl) phenyl) diselanyl) phenyl) ethylimino) methyl) phenol.
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say. Lipid peroxidation was determined by measuring (TBARS) as
described by Ohkawa et al. [8] with a slight modiﬁcation that pH
of the incubation medium was changed from 5.4 to 7.4 (i.e. 5.4,
5.8, 6.4. 6.8 and 7.4).
3. Results and discussion
Two-way analysis of variance (ANOVA) of Fe (II)-induced TBARS
levels in rat’s brain, kidney, liver and phospholipids extract from
egg yolk revealed a signiﬁcant main effect of pH and Fe (II) and also
a signiﬁcant Fe  pH interaction (P < 0.05). Indeed, lipid peroxida-
tion in the absence of Fe (II) is enhanced upon a shift in the pH of
the incubation solutions from physiological conditions (pH 7.4) to
acidic ones (pH 5.4) as shown in (Fig. 2). Similarly, the amount of
TBARS produced by incubation of homogenate and phospholipids
extract with Fe (II) alone at pH 7.4 was lower. However, as theFig. 2. Effect of pH on basal (shaded bar) or Fe (II)-induced (bar with lines) TBARS product
The values are expressed as nmol of MDA per gram of tissue. Data are expressed as means
while asterisk shows signiﬁcant main effect of Fe (II) at P < 0.05.pH of the solution was decreased from 7.4 to 5.4, Fe (II)-dependent
TBARS production markedly increased as shown in (Fig. 2).
The enhancement of pH dependent lipid peroxidation can be
attributed to mobilized iron, which may come from reserves where
it is weakly bound. It has been shown that the protein transferrin
carries two iron ions, although only about one third of it is nor-
mally saturated with iron [9]. Transferrin loses its bound iron at
acidic pH. The initial 10% of iron in saturated human transferrin
is lost at a pH of 5.4 and the ﬁnal 10% at a pH of 4.3 [10]. On the
other hand, if transferrin is bound to its receptor, essentially all
the iron is released at pH 5.6–6.0 [11]. The pH-dependent afﬁnity
of transferrin for iron decreases under acidic conditions leading
to dissociation of iron from transferrin and other proteins like fer-
ritin and lactoferrin [12]. Once mobilized, free iron likely binds
non-speciﬁcally to a variety of small molecular moieties and aug-
ments the ordinarily small low molecular weight (LMW) non-pro-
tein-bound tissue pool. In cortical homogenates, striking increases
in LMW iron are observed at pH 6.0 when pH is reduced from 7.0
by direct addition of lactic acid. Furthermore, brain from decapi-
tated hyperglycemic rats shows elevated LMW iron relative to nor-
moglycemic controls [13]. The mobilized iron Fe (II) can interact
with enzymatically and/or non-enzymatically generated superox-
ide (O12 ) (Haber–Weiss reaction) and/or hydrogen peroxide
(H2O2) (Fenton reaction) [14,15] producing reactive oxygen spe-
cies. In fact, O12 and H2O2 may be produced directly from dis-
solved oxygen (O2) in aqueous media in the Fe (II)-mediated
basal/autooxidation reactions as follows:
Fe2þ þ O2 ! Fe3þ þ O12 ð1Þ
The dismutation of superoxide to hydrogen peroxide and oxygen
has been shown to be faster at acidic pH [13]
HO2 þ O12 þHþ ! H2O2 þ O2 ð2Þion in rat’s brain, kidney, liver homogenate and phospholipids extract from egg yolk.
± S.E.M. (n = 5–7). Different letters shows signiﬁcant difference from each pH group
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may react together in a metal catalyzed (Haber–Weiss reaction)
to produce the extremely reactive hydroxyl radical, which may then
abstract hydrogen atoms from polyunsaturated fatty acids
Fe2þ þ O12 þ 2Hþ ! Fe3þ þH2O2 ð3Þ
Fe2þ þH2O2 ! Fe3þ þ OH1 þ OH ð4Þ
Ferrous ion (Fe (II)) is the form of iron that is capable of redox cy-
cling. Oxidation of Fe (II) to Fe (III) resulting in ROS formation is
greatly dependent upon the pH of the media. The possibility of
reduction of Fe (III) to Fe (II) by interaction with O12 at the early
phase of lipid peroxidation under acidic conditions, perhaps via
an intermediate, perferryl iron [16], cannot be excluded
Fe2þ þ O2 ! Fe3þ þ O12 ð5Þ
Fe3þ þ O12 ! ½Fe3þ  O12 $ Fe2þ  O2 $ Fe2þ þ O2 ð6Þ
This pH environment and a series of chain reactions (1)–(6) seem to
provide optimal conditions for maximal catalytic efﬁciency of iron.
Thus, the acidic pH not only release iron from ‘‘safe” sites [11], but
also potentiate the pro-oxidant effect of Fe (II), as we observed from
signiﬁcant increase in TBARS production at pH (6.8–5.4) in all tested
homogenates and phospholipids extract (Fig. 2). The results are
consistent with our previous observation that low pH indeed en-
hanced lipid peroxidation processes in brain and phospholipid ex-
tract [17,18].
Three way ANOVA of TBARS production, i.e. 6 pHs  5 concen-
trations of Compound A  2 (basal/iron) revealed a signiﬁcant
main effect of pH, Compound A and Fe (II). For the sake of clarity,
data from the anti-oxidant effect of Compound A at different pHFig. 3. Effect of Compound A on basal (shaded bar) or Fe (II)-induced (bar with lines) TBA
nmol of MDA per gram of tissue. Data are expressed as means ± S.E.M. (n = 5–7). Diff
signiﬁcant main effect of Fe (II) at P < 0.05.values and in the presence or absence of added Fe (II), which was
analyzed by a three way ANOVA, was further analyzed by two-
way ANOVA at each pH. Two-way ANOVA for TBARS production
at all studied pH values revealed a signiﬁcant main effect of Fe
(II) and Compound A (P < 0.05 for all pH values) and also a signiﬁ-
cant Fe (II)  Compound A interaction (P < 0.05 for all pH values). It
is possible to observe that Fe (II) increased TBARS production in all
tested homogenates (Figs. 3–5), while, Compound A signiﬁcantly
reduced it.
Compound A also signiﬁcantly reduced both basal and Fe (II)-in-
duced TBARS at all studied pH values in phospholipids extract as
shown in (Fig. 6). Data from the literature revealed the fact that
Fe (II)-dependent TBARS production in phospholipids liposomes
under acidic condition is not inhibited by the addition of SOD, cat-
alase and OH scavengers (mannitol, sodium benzoate and dim-
ethylthiourea) [19]. The lack of action of SOD, catalase and OH
scavengers in Fe (II)-dependent TBARS production suggests that
other species rather than O12 , H2O2 and
OH are involved in the ini-
tiation of Fe (II)-dependent lipid peroxidation. Several investiga-
tors have proposed some iron–oxygen complexes such as the
ferryl ion [20], perferryl ion [16] and Fe2þ—O2—Fe
3þ complexes
[21] for oxidizing species of Fe (II). A plausible mechanism by
which Compound A is conferring protective action against Fe (II)-
induced lipid peroxidation in these extracts is that Compound A
could not only be working as a scavenger, but may also be interact-
ing directly with Fe (II) or its oxidized forms. The reduced form of
the compound was expected to be a good reducing agent, one that
would be readily reactive towards ROS. However, contrary to our
expectations, we did not ﬁnd any alteration in the anti-oxidant
activity with respect to pH of Compound A at all studied pH values.RS production in rat’s brain homogenate at different pH. The values are expressed as
erent letters shows signiﬁcant difference from basal group, while asterisk shows
Fig. 5. EffectofCompoundAonbasal (shadedbar)orFe(II)-induced(barwith lines)TBARSproduction inrat’s liverhomogenateatdifferentpH.ThevaluesareexpressedasnmolofMDAper
gramof tissue.Data are expressed asmeans ± S.E.M. (n = 5–7).Different letters shows signiﬁcant difference frombasal group,while asteric shows signiﬁcantmain effect of Fe (II) atP < 0.05.
Fig. 4. Effect of Compound A on basal (shaded bar) or Fe (II)-induced (bar with lines) TBARS production in rat’s kidney homogenate at different pH. The values are expressed
as nmol of MDA per gram of tissue. Data are expressed as means ± S.E.M. (n = 5–7). Different letters shows signiﬁcant difference from basal group, while asteric shows
signiﬁcant main effect of Fe (II) at P < 0.05.
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Fig. 6. Effect of Compound A on basal (shaded bar) or Fe (II)-induced (bar with lines) TBARS production in phospholipids extract from egg yolk at different pH. The values are
expressed as nmol of MDA per gram of tissue. Data are expressed as means ± S.E.M. (n = 5–7). Different letters shows signiﬁcant difference from basal group, while asteric
shows signiﬁcant main effect of Fe (II) at P < 0.05.
W. Hassan et al. / FEBS Letters 583 (2009) 1011–1016 1015In the present work, we demonstrated for the ﬁrst time the anti-
oxidant effect of Compound A on Fe (II)-induced lipid peroxidation
in rat’s tissue homogenates and phospholipids extract in vitro, not
only at physiological pH but also under acidic conditions. These
results support the anti-oxidant potential of Compound A and a
possible direct interaction with Fe (II) or its oxidized derivatives.
Although the observation in the present study cannot be directly
related to in vivo conditions, it seems that the results may
give us a clue to understand the role of Fe (II) in the iron-mediated
cell injury and/or diseases under acidic conditions and a possi-
ble anti-oxidant effect of Compound A in ischemic/reperfusion
injury.
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